Moreover, FGFR inhibition did not markedly affect the mRNA levels of NF-κB pathway receptors or ligands (other than TNFSF15, whose receptor, TNFRSF25 shows very low mRNA expression in ICC cells) (Supplementary Fig. 5o). The gene discussed is NFKB1; the disease is intrahepatic cholangiocarcinoma.